Drug Shortage Report for CHORIONIC GONADOTROPIN FOR INJECTION, USP
Report ID | 220032 |
Drug Identification Number | 02247459 |
Brand name | CHORIONIC GONADOTROPIN FOR INJECTION, USP |
Common or Proper name | CHORIONIC GONADOTROPIN FOR INJECTION, USP |
Company Name | FRESENIUS KABI CANADA LTD |
Market Status | MARKETED |
Active Ingredient(s) | CHORIONIC GONADOTROPIN |
Strength(s) | 10000UNIT |
Dosage form(s) | POWDER FOR SOLUTION |
Route of administration | SUBCUTANEOUS INTRAMUSCULAR SUBCUTANEOUS INTRAMUSCULAR |
Packaging size | 10000UNIT |
ATC code | G03GA |
ATC description | GONADOTROPHINS AND OTHER OVULATION STIMULANTS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2024-02-26 |
Estimated end date | 2024-03-25 |
Actual end date | 2024-03-22 |
Shortage status | Resolved |
Updated date | 2024-03-23 |
Company comments | We regret to advise that we will be experiencing a backorder on this product. |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 165 GALAXY BLVD, SUITE 100 TORONTO, ONTARIO CANADA M9W 0C8 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v6 | 2024-03-23 | English | Compare |
v5 | 2024-03-22 | French | Compare |
v4 | 2024-03-22 | English | Compare |
v3 | 2024-02-27 | English | Compare |
v2 | 2024-02-20 | French | Compare |
v1 | 2024-02-20 | English | Compare |
Showing 1 to 6 of 6